EA
RMD icon

Emerald Acquisition’s ResMed RMD Stock Holding History

Emerald Acquisition’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$20.5M Sell
315,746
-54,558
-15% -$3.63M 0.04% 516
2016
Q2 		$23.4M Buy
+370,304
New +$21.8M 0.04% 522

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Emerald Acquisition's RMD Position: Q3 2016 in Review

Emerald Acquisition reduced its ResMed (RMD) stake by 15% in Q3 2016, selling an estimated $3.63M and leaving 315,746 shares worth $20.5M. The position accounts for 0.04% of the portfolio, ranked #516.

Emerald Acquisition first reported a position in RMD in Q2 2016 and has held it in 2 quarters since. The position peaked at $23.4M in Q2 2016. 373 funds tracked by Wall St. Rank hold RMD as of Q3 2016.

  • Emerald Acquisition held 315,746 shares of ResMed worth $20.5M as of Q3 2016.
  • Emerald Acquisition sold 54,558 ResMed shares in Q3 2016, an estimated $3.63M.
  • ResMed made up 0.04% of Emerald Acquisition's portfolio in Q3 2016, its #516 holding.
  • Emerald Acquisition first reported a position in ResMed in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's ResMed position peaked at $23.4M in Q2 2016.
  • 373 funds tracked by Wall St. Rank held ResMed as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.